Comparisons of clinical outcomes
| Clinical outcome | Prehabilitation group | CRC control group |
| Length of stay | Median 12 days | Median 10 days |
| Complication rate | 50% | 67% |
| Clavien Dindo Score | 0=24 | 0=15 |
| 1=4 | 1=6 | |
| 2=9 | 2=23 | |
| 3a=3 | 3a=2 | |
| 3b=4 | 3b=2 | |
| 4a=2 | 4a=1 | |
| 4b=0 | 4b=1 | |
| 5=1 | 5=0 | |
| (P=0.06) | ||
| Unplanned intensive care admission | 7 (14%) | 0 |
| 30-day readmission rate | 4 (8%) | 0 |
| Days alive outside hospital at 30 days | Average 19.5 days | Average 20 days (p=0.08) |
Results from PDSA 2 cycle did not demonstrate any statistically significant differences in clinical outcomes.
CRC, colorectal cancer; PDSA, Plan–Do–Study–Act.